Want to see TSE:HLS full AI Analyst Report?
HLS Therapeutics Inc (HLS) Income Statement
HLS Therapeutics Inc Income Statement
Last quarter (Q2 2026), HLS Therapeutics Inc's total revenue was $14.29M, an increase of 0.87% from the same quarter last year. In Q2, HLS Therapeutics Inc's net income was $-993.67K. See HLS Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 56.47M | $ 56.62M | $ 63.07M | $ 61.47M | $ 60.01M | |
| $ 24.01M | $ 47.62M | $ 55.45M | $ 56.49M | $ 56.04M | |
| $ 28.19M | $ 55.31M | $ 55.45M | $ 69.98M | $ 62.32M | |
| Depreciation and Amortization | $ 22.20M | $ 22.72M | $ 31.94M | $ 34.40M | $ 30.26M |
| $ 18.02M | $ 17.22M | $ 12.88M | $ 18.00M | $ 25.41M | |
| ― | $ -7.69M | $ -10.35M | $ -13.44M | $ -6.24M | |
| $ -8.92M | $ -7.90M | $ -17.45M | $ -10.22M | $ -5.52M | |
| $ -13.10M | $ -15.58M | $ -27.80M | $ -23.72M | $ -11.81M | |
| $ -12.65M | $ -19.66M | $ -27.53M | $ -23.60M | $ -13.12M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.40 | $ -0.62 | $ -0.85 | $ -0.73 | $ -0.41 |
| Diluted EPS | $ -0.40 | $ -0.62 | $ -0.85 | $ -0.73 | $ -0.41 |
| Weighted Average Shares Outstanding | 31.53M | 31.84M | 32.26M | 32.33M | 32.18M |
| Weighted Average Shares Outstanding (Diluted) | 31.53M | 31.84M | 32.26M | 32.43M | 32.18M |
Currency in USD
